Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124614922 | 12461492 | 2 | F | 2000 | 20160715 | 20160613 | 20160725 | EXP | US-PFIZER INC-2016289997 | PFIZER | 78.00 | YR | M | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124614922 | 12461492 | 1 | PS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | 40 MG, 1X/DAY | 20702 | 40 | MG | QD | ||||||||
| 124614922 | 12461492 | 2 | C | DICLOFENAC SODIUM. | DICLOFENAC SODIUM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124614922 | 12461492 | 1 | Blood cholesterol decreased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124614922 | 12461492 | HO |
| 124614922 | 12461492 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124614922 | 12461492 | Activities of daily living impaired | |
| 124614922 | 12461492 | Apparent death | |
| 124614922 | 12461492 | Drug hypersensitivity | |
| 124614922 | 12461492 | Dyskinesia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124614922 | 12461492 | 1 | 2000 | 0 | ||
| 124614922 | 12461492 | 2 | 20160529 | 20160610 | 0 |